22alpha-acetyl-16alpha-hydroxyolean-12-en-28-al 3-O-[alpha-rhamnopyranosyl-(1''''→6''')-beta-glucopyranosyl-(1'''→3')] [beta-glucopyranosyl-(1''→2')]-beta-arabinopyranoside - Compound Card

22alpha-acetyl-16alpha-hydroxyolean-12-en-28-al 3-O-[alpha-rhamnopyranosyl-(1''''→6''')-beta-glucopyranosyl-(1'''→3')] [beta-glucopyranosyl-(1''→2')]-beta-arabinopyranoside

Select a section from the left sidebar

22alpha-acetyl-16alpha-hydroxyolean-12-en-28-al 3-O-[alpha-rhamnopyranosyl-(1''''→6''')-beta-glucopyranosyl-(1'''→3')] [beta-glucopyranosyl-(1''→2')]-beta-arabinopyranoside

Structure
Zoomed Structure
  • Family: Plantae - Myrsinaceae
  • Kingdom: Plantae
  • Class: Terpenoid
Canonical Smiles OC[C@@H]1OC(O[C@@H]2C(OC[C@H]([C@H]2OC2O[C@H](COC3O[C@H](C)[C@H]([C@@H]([C@@H]3O)O)O)[C@H]([C@@H]([C@H]2O)O)O)O)O[C@H]2CC[C@]3(C(C2(C)C)CC[C@@]2(C3CC=C3[C@@]2(C)CC([C@@]2(C3CC(C)(C)C[C@@H]2OC(=O)C)C=O)O)C)C)[C@H]([C@@H]([C@H]1O)O)O
InChI InChI=1S/C55H88O23/c1-23-35(61)38(64)41(67)46(72-23)71-21-29-37(63)40(66)43(69)48(75-29)77-44-27(59)20-70-49(45(44)78-47-42(68)39(65)36(62)28(19-56)74-47)76-33-13-14-52(7)30(51(33,5)6)12-15-53(8)31(52)11-10-25-26-16-50(3,4)18-34(73-24(2)58)55(26,22-57)32(60)17-54(25,53)9/h10,22-23,26-49,56,59-69H,11-21H2,1-9H3/t23-,26?,27-,28+,29-,30?,31?,32?,33+,34+,35-,36+,37-,38+,39-,40+,41+,42+,43-,44-,45+,46?,47?,48?,49?,52+,53-,54-,55+/m1/s1
InChIKey WASKJNBEERGVGS-ZEHWERMNSA-N
Formula C55H88O23
HBA 23
HBD 12
MW 1117.29
Rotatable Bonds 12
TPSA 359.97
LogP -1.18
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 78
Formal Charge 0
Fraction CSP3 0.93
Exact Mass 1116.57
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Maesa lanceolata Myrsinaceae Plantae 992730

Showing of synonyms

  • Manguro LO, Midiwo JO, et al. (2011). Triterpene saponins of Maesa lanceolata leaves.. Arkivoc,2011,ii,172-198. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1OCC2CCCC(O2)OC(C3OC4CCCCO4)CCOC3OC(CC5)CC(CC6)C5C(CC7)C6C(C=78)CCC9C8CCCC9

Level: 4

Mol. Weight: 1117.29 g/mol

Structure

SMILES: O1CCCCC1OCC2CCCC(O2)OC3CC(OCC3)OC(CC4)CC(CC5)C4C(CC6)C5C(C=67)CCC8C7CCCC8

Level: 3

Mol. Weight: 1117.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6OCCC(OC7CCCCO7)C6OC8CCCCO8

Level: 3

Mol. Weight: 1117.29 g/mol

Structure

SMILES: O1CCCCC1OCC2CCCC(O2)OC3C(COCC3)OC4CCCCO4

Level: 3

Mol. Weight: 1117.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC(OCCC6)C6OC7CCCCO7

Level: 2

Mol. Weight: 1117.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC(OCC6)CC6OC7CCCCO7

Level: 2

Mol. Weight: 1117.29 g/mol

Structure

SMILES: O1CCCCC1OCC2CCCC(O2)OC3CCOCC3

Level: 2

Mol. Weight: 1117.29 g/mol

Structure

SMILES: O1CCCCC1OC2C(COCC2)OC3CCCCO3

Level: 2

Mol. Weight: 1117.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6CCCCO6

Level: 1

Mol. Weight: 1117.29 g/mol

Structure

SMILES: O1CCCCC1COC2CCCCO2

Level: 1

Mol. Weight: 1117.29 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1117.29 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1117.29 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 1117.29 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1117.29 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.46
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
1181040.73
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
154349087.73

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.62
Plasma Protein Binding
59.15
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
1.48
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-3589804.78
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-2.25
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-280136168128.39
Rat (Acute)
3.98
Rat (Chronic Oral)
600.71
Fathead Minnow
353612521.63
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
31507548382.18
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-17503.28
Log(P)
-1.62
Log S
-2.61
Log(Vapor Pressure)
-1037527288.15
Melting Point
202.37
pKa Acid
-7559924.28
pKa Basic
-60810.49
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Transcriptional activator, LuxR/UhpA family of regulators Q7NQP7 Q7NQP7_CHRVO Chromobacterium violaceum 3 0.7552
Transcriptional activator, LuxR/UhpA family of regulators Q7NQP7 Q7NQP7_CHRVO Chromobacterium violaceum 3 0.7552
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7017
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7017

Download SDF